Regorafenib cancer drug. This oral multi-kinase inhibitor cancer drug,sold under the trade name Stivarga,is used to treat metastatic colorectal cancer and advanced gastrointestinal stromal tumours. It was developed by the Bayer pharmaceutical company and studied from 2009 onwards,with approvals for medical use granted from 2012 | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 3478 px × 5038 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|